Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
What is This Site Help Center Crisis
Powered By

Top 10 search results for "Pomalyst" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
Understanding Heart Disease and Myeloma Treatment
... Thalidomide (Thalomid), lenalidomide (Revlimid), and pomalidomide (Pomalyst) are immunomodulators that may increase the chance of cardiovascular complications, particularly when used together with dexamethasone. ...
Understanding Heart Disease and Myeloma Treatment
... Thalidomide (Thalomid), lenalidomide (Revlimid), and pomalidomide (Pomalyst) are immunomodulators that may increase the chance of cardiovascular complications, particularly when used together with dexamethasone. ...
Medications for Multiple Myeloma: Your Guide
... Therefore, drugs may be used more often than chemo.Immunomodulatory DrugsThe goal of immunomodulatory drugs is to help activate the immune system against cancer cells.Immunomodulatory drugs include: Pomalyst (pomalidomide) Revlimid (lenalidomide) Thalomid (thalidomide) Side effects of immunomodulatory drugs include fatigue, neuropathy (painful damage ...
Medications for Multiple Myeloma: Your Guide
... Therefore, drugs may be used more often than chemo.Immunomodulatory DrugsThe goal of immunomodulatory drugs is to help activate the immune system against cancer cells.Immunomodulatory drugs include: Pomalyst (pomalidomide) Revlimid (lenalidomide) Thalomid (thalidomide) Side effects of immunomodulatory drugs include fatigue, neuropathy (painful damage ...
Anemia With Multiple Myeloma: What You Need To Know
... While these medications work in different ways to treat myeloma, they can sometimes cause anemia as a side effect.For example, pomalidomide (Pomalyst), an immunomodulatory drug, has been known to cause anemia in some people. ...
Anemia With Multiple Myeloma: What You Need To Know
... While these medications work in different ways to treat myeloma, they can sometimes cause anemia as a side effect.For example, pomalidomide (Pomalyst), an immunomodulatory drug, has been known to cause anemia in some people. ...
Amyloidosis: How Is It Different From Multiple Myeloma?
... These drugs include: Elotuzumab (Empliciti) Carfilzomib (Kyprolis) Ixazomib (Ninlaro) Bortezomib (Boruzu and Velcade) Another category of medication called immunomodulatory drugs — which includes lenalidomide (Revlimid) and pomalidomide (Pomalyst) — can help the body fight AL amyloidosis or myeloma. ...
Amyloidosis: How Is It Different From Multiple Myeloma?
... These drugs include: Elotuzumab (Empliciti) Carfilzomib (Kyprolis) Ixazomib (Ninlaro) Bortezomib (Boruzu and Velcade) Another category of medication called immunomodulatory drugs — which includes lenalidomide (Revlimid) and pomalidomide (Pomalyst) — can help the body fight AL amyloidosis or myeloma. ...
Infections and Myeloma: How To Lower Your Risk
... Because of this, many MM treatments are a significant risk factor for infections.Therapies for myeloma that increase infection vulnerability include: Immunomodulatory drugs Chemotherapy drugs Radiation therapy Steroids Stem cell transplantation Immunomodulatory DrugsImmunomodulatory drugs, including lenalidomide (Revlimid) and pomalidomide (Pomalyst ...
Infections and Myeloma: How To Lower Your Risk
... Because of this, many MM treatments are a significant risk factor for infections.Therapies for myeloma that increase infection vulnerability include: Immunomodulatory drugs Chemotherapy drugs Radiation therapy Steroids Stem cell transplantation Immunomodulatory DrugsImmunomodulatory drugs, including lenalidomide (Revlimid) and pomalidomide (Pomalyst ...
Can Multiple Myeloma Be Cured? Advances in Research and Survival
... Common iMiDs include thalidomide (Thalomid), lenalidomide (Revlimid), and pomalidomide (Pomalyst). CAR T-cell therapy — Also called adoptive cell therapy, this is a personalized immunotherapy that modifies a person’s T cells to fight myeloma. FDA-approved options include idecabtagene vicleucel (Abecma) and ciltacabtagene autoleucel (Carvykti). ...
Can Multiple Myeloma Be Cured? Advances in Research and Survival
... Common iMiDs include thalidomide (Thalomid), lenalidomide (Revlimid), and pomalidomide (Pomalyst). CAR T-cell therapy — Also called adoptive cell therapy, this is a personalized immunotherapy that modifies a person’s T cells to fight myeloma. FDA-approved options include idecabtagene vicleucel (Abecma) and ciltacabtagene autoleucel (Carvykti). ...
Bispecific T-Cell Engagers for RRMM: 6 Facts About a New Type of Treatment
... Available options for RRMM include: Immunomodulatory drugs like lenalidomide (Revlimid) and pomalidomide (Pomalyst) Proteasome inhibitors like bortezomib (Boruzu and Velcade) and carfilzomib (Kyprolis) Immunotherapies such as daratumumab (Darzalex) and elotuzumab (Empliciti) Chimeric antigen receptor T-cell therapy (CAR T-cell therapy) These drugs may ...
Bispecific T-Cell Engagers for RRMM: 6 Facts About a New Type of Treatment
... Available options for RRMM include: Immunomodulatory drugs like lenalidomide (Revlimid) and pomalidomide (Pomalyst) Proteasome inhibitors like bortezomib (Boruzu and Velcade) and carfilzomib (Kyprolis) Immunotherapies such as daratumumab (Darzalex) and elotuzumab (Empliciti) Chimeric antigen receptor T-cell therapy (CAR T-cell therapy) These drugs may ...
New Treatment Options for Relapsed or Refractory Myeloma
... Recently approved treatment regimens include: Daratumumab hyaluronidase-fihj in combination with the immunomodulatory drug pomalidomide (Pomalyst) and the corticosteroid dexamethasone for people with myeloma who have already tried at least one other treatment Daratumumab, dexamethasone, and lenalidomide, an immunomodulating agent (a substance that ...
New Treatment Options for Relapsed or Refractory Myeloma
... Recently approved treatment regimens include: Daratumumab hyaluronidase-fihj in combination with the immunomodulatory drug pomalidomide (Pomalyst) and the corticosteroid dexamethasone for people with myeloma who have already tried at least one other treatment Daratumumab, dexamethasone, and lenalidomide, an immunomodulating agent (a substance that ...
Chemotherapy for Multiple Myeloma: Your Guide
... Immunomodulatory drugs used to treat myeloma include thalidomide (Thalomid), lenalidomide (Revlimid), and pomalidomide (Pomalyst).Targeted Therapy DrugsTargeted therapies recognize certain genes or proteins found in cancer cells. ...
Chemotherapy for Multiple Myeloma: Your Guide
... Immunomodulatory drugs used to treat myeloma include thalidomide (Thalomid), lenalidomide (Revlimid), and pomalidomide (Pomalyst).Targeted Therapy DrugsTargeted therapies recognize certain genes or proteins found in cancer cells. ...
What Is the Life Expectancy With Relapsed/Refractory Myeloma?
... , previous treatments, and test results.Treatment options for RRMM include: Immunotherapy with chimeric antigen receptor T-cell therapy (CAR T-cell therapy) using such options as idecabtagene vicleucel (Abecma) and ciltacabtagene autoleucel (Carvykti) Proteasome inhibitors like carfilzomib (Kyprolis) and ixazomib (Ninlaro) IMiDs like pomalidomide (Pomalyst ...
What Is the Life Expectancy With Relapsed/Refractory Myeloma?
... , previous treatments, and test results.Treatment options for RRMM include: Immunotherapy with chimeric antigen receptor T-cell therapy (CAR T-cell therapy) using such options as idecabtagene vicleucel (Abecma) and ciltacabtagene autoleucel (Carvykti) Proteasome inhibitors like carfilzomib (Kyprolis) and ixazomib (Ninlaro) IMiDs like pomalidomide (Pomalyst ...